BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23551022)

  • 21. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
    Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
    Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease.
    Wilkinson TM; Donaldson GC; Hurst JR; Seemungal TA; Wedzicha JA
    Am J Respir Crit Care Med; 2004 Jun; 169(12):1298-303. PubMed ID: 14990395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis.
    Yu AP; Yang H; Wu EQ; Setyawan J; Mocarski M; Blum S
    J Med Econ; 2011; 14(3):315-23. PubMed ID: 21500975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of Frequent Exacerbator Phenotype in Patients with Chronic Obstructive Pulmonary Disease.
    Krachunov I; Kyuchukov N; Ivanova Z; Yanev NA; Hristova PA; Pavlov P; Glogovska P; Popova T; Ivanov YY
    Folia Med (Plovdiv); 2018 Dec; 60(4):536-545. PubMed ID: 31188775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of chronic obstructive pulmonary disease exacerbations.
    Ishii T; Kida K
    Curr Opin Pulm Med; 2014 Mar; 20(2):138-45. PubMed ID: 24406871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of successive COPD exacerbations.
    Wedzicha JA; Donaldson GC
    Thorax; 2012 Nov; 67(11):935-6. PubMed ID: 22858927
    [No Abstract]   [Full Text] [Related]  

  • 29. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
    Soler-Cataluña JJ; Rodriguez-Roisin R
    COPD; 2010 Aug; 7(4):276-84. PubMed ID: 20673037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations.
    Pauwels RA
    Proc Am Thorac Soc; 2004; 1(2):73-6. PubMed ID: 16113416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
    Fan VS; Ramsey SD; Make BJ; Martinez FJ
    COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early identification of exacerbations in patients with chronic obstructive pulmonary disease.
    Yawn BP
    J Prim Care Community Health; 2013 Jan; 4(1):75-80. PubMed ID: 23799693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
    Niewoehner DE
    Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study.
    Effing T; Kerstjens H; van der Valk P; Zielhuis G; van der Palen J
    Thorax; 2009 Nov; 64(11):956-62. PubMed ID: 19736179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definition, epidemiology and natural history of COPD.
    Viegi G; Pistelli F; Sherrill DL; Maio S; Baldacci S; Carrozzi L
    Eur Respir J; 2007 Nov; 30(5):993-1013. PubMed ID: 17978157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
    Jones PW; Agusti AG
    Eur Respir J; 2006 Apr; 27(4):822-32. PubMed ID: 16585091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
    Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
    COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the COPD severity score for use in primary care: the NEREA study.
    Miravitlles M; Llor C; de Castellar R; Izquierdo I; Baró E; Donado E
    Eur Respir J; 2009 Mar; 33(3):519-27. PubMed ID: 19164354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing hospitalization for COPD exacerbations.
    Bourbeau J
    Semin Respir Crit Care Med; 2010 Jun; 31(3):313-20. PubMed ID: 20496300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.